Jeremy Haigh, VP International Chief Operating Officer for R&D, Amgen: "I am delighted and honoured that for the second consecutive eyar, Amgen has been seen its indusry peers to have the best new drug, and I think that really shows that we are able to deliver the promise of our pipeline."
Link to this comment:
All Comments (0)